GLYGARD 40mg TABLET

Description

Glygard 40 Tablet is an oral antidiabetic medication manufactured by Cipla Ltd. It contains Gliclazide 40mg, a sulfonylurea group drug widely prescribed for the management of Type 2 Diabetes Mellitus.

Gliclazide works by stimulating the pancreatic beta cells to release more insulin, thereby lowering blood glucose levels. Along with promoting insulin secretion, it also improves the body’s utilization of glucose, helping maintain stable sugar control. By controlling blood sugar effectively, Glygard 40 helps prevent serious diabetes-related complications such as nerve damage, kidney impairment, vision problems, and cardiovascular diseases.

This medicine is usually recommended when lifestyle measures like diet control and exercise alone are insufficient. It is generally taken once or twice daily with meals to reduce the risk of low blood sugar episodes.

Possible side effects include hypoglycemia (low blood sugar), dizziness, headache, mild nausea, or stomach discomfort. To avoid hypoglycemia, patients should not skip meals and should carry a source of sugar like glucose tablets or candy. Regular monitoring of blood sugar levels is important during therapy.

Glygard 40 Tablet is considered effective and well-tolerated, especially in patients requiring a lower dose of gliclazide to control their diabetes. It helps improve quality of life by keeping blood sugar in check and reducing the chances of long-term health complications.